All News #Library
Biotech
First Patient Dosed In Brain Injury Drug Study In Canada
24 Mar 2026 //
BUSINESSWIRE
Vasomune’s AV-001 Gets IDSMB Approval for Phase 2a Study
03 Dec 2024 //
BUSINESSWIRE
Vasomune: FDA Fast Track For Investigational Medicine AV-001
28 May 2024 //
BUSINESSWIRE
ATS Selects Vasomune For AV-001 Respiratory Summit
15 Apr 2024 //
BUSINESSWIRE

Market Place
Sourcing Support